2018 American Transplant Congress
Amiodarone Use Increases Morbidity Not Mortality in Pediatric Heart Transplant Recipients
Pediatric Cardiology, St.Louis Children's Hospital, St. Louis, MO.
Background: Amiodarone is commonly used in pediatric and adult patients with end-stage heart failure and its use is associated with increased 1-year post-transplant mortality in…2018 American Transplant Congress
External Validation of Hennepin Transplant Risk Score for Prediction of Short-Term Mortality and Morbidity after Deceased Kidney Transplantation
Introduction: The additive or synergistic effects of multiple co-morbidities at the time of listing on transplant survival is still unclear. Objective scoring systems predicting post-transplant…2018 American Transplant Congress
Follow-Up and Outcomes of Epstein-Barr Virus Negative Recipients after a Kidney Transplant from an Epstein-Barr Virus Positive Donor
Introduction: Post-transplant lymphoproliferative disorder (PTLD) is one of the most serious complications of chronic immunosuppression after an organ transplant. One of the major risk factors…2018 American Transplant Congress
Can We Optimise Immunosuppression Strategies in Our Older Renal Transplant Recipients?
Renal transplantation provides a survival advantage for patients including those with multiple co-morbidities and older age compared to remaining on dialysis. The optimal immunosuppressive regime…2018 American Transplant Congress
Temporary Contraindication of Obese Recipients in Kidney Transplantation: A New Morphometric Tool for Decision Support
IntroductionBased on body mass index (BMI) and/or clinical examination, morbid obesity can be a temporary contraindication (TCI) of kidney transplantation. However, BMI alone does not…2018 American Transplant Congress
Urological Complications of Prophylactic Ureteral Stent vs. No Stent in Kidney Transplant Recipients at Erie County Medical Center (ECMC)
Introduction:Complications after kidney transplant (tx) commonly originate from ureterovesical anastomosis, it accounts for 3-9% of urinary complications. Due to the difference in the surgical preference,…2018 American Transplant Congress
Specialized Transplant Critical Care Model Improves Access to Transplantation and Short-Term Survival Outcomes after Liver Transplantation in the Highest Acuity Patients
Objective: Liver transplantation (LT) is a lifesaving treatment for end stage liver disease (ESLD). High acuity ESLD patients are disadvantaged as they are frequently denied…2017 American Transplant Congress
Performance-Based vs. Self-Reported Functional Assessment on Outcomes After Kidney Transplant.
Renal and Pancreas Transplant Department, Saint Barnabas Medical Center, Livingston, NJ
Reduced functional capacity (FC) is associated with poor outcomes and early hospital readmission after kidney transplant (KT). The aim of the study was to determine…2017 American Transplant Congress
State Population Health and Center-Level Variation in Rate of Living Kidney Donation.
University of Alabama at Birmingham, Birmingham
Background: Comorbid conditions that exclude individuals from living kidney donation are highly prevalent in the United States, but the relationship between population characteristics and the…2017 American Transplant Congress
A Comparison of Desensitization Protocols: Rituximab with/without Plasmapheresis in ABO-Incompatible Living Donor Liver Transplantation.
Center for Liver Cancer, National Cancer Center, Goyang, Korea
Background: Plasmapheresis is a desensitization method used prior to ABO-incompatible (ABO-I) living donor liver transplantation (LDLT). However, studies on its usefulness in the rituximab era…
- « Previous Page
- 1
- …
- 6
- 7
- 8
- 9
- 10
- …
- 12
- Next Page »